Rigosertib ameliorates the effects of oncogenic KRAS signaling in a murine model of myeloproliferative neoplasia

Aberrant signaling triggered by oncogenic or hyperactive RAS proteins contributes to the malignant phenotypes in a significant percentage of myeloid malignancies. Of these, juvenile myelomonocytic leukemia (JMML), an aggressive childhood cancer, is largely driven by mutations in RAS genes and those...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Baker, Stacey J., Cosenza, Stephen C., Ramana Reddy, M.V., Premkumar Reddy, E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2019
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6443005/
https://ncbi.nlm.nih.gov/pubmed/30956775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26735
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items